Back

Coordinated post-myocardial infarction care versus the PCSK9 modulator drug program: a comparative outcomes study

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Contemporary pharmacotherapy after acute coronary syndromes: beta-blockers, lipids, and platelet inhibition Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Maciej Banach

Medical University of Lodz, Lodz (Poland)

5 More presentations in this session

Presentation thumbnail
Effect of beta-blockers on cardiovascular hospitalisation after myocardial infarction: A substudy of the BETAMI-DANBLOCK trial.
Doctor H. Caglar (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Troponin-stratified outcomes of extended clopidogrel monotherapy versus dual antiplatelet therapy in acute coronary syndrome: insights from the OPT-BIRISK randomized trial
Professor M. Qiu (Shenyang, CN)
Abstract Slides Video
Presentation thumbnail
Long-term effect of beta-blockers after myocardial infarction with preserved left ventricular ejection fraction in a per protocol analysis of the REDUCE-AMI trial
Professor T. Jernberg (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Long-term clinical outcomes of beta-blocker therapy in elderly patients with preserved left ventricular function after percutaneous coronary intervention for acute myocardial infarction
Assistant Professor J. Choe (Pusan, KR)
Abstract Slides Video
Presentation thumbnail
Influence of diabetes on platelet inhibition in patients with acute coronary syndrome treated with prasugrel or ticagrelor
Doctor F. Simonetti (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Contemporary pharmacotherapy after acute coronary syndromes: beta-blockers, lipids, and platelet inhibition

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Long-term survival of heFH or ACS patients on PCSK9 targeted therapy based on the real-life data from poland
30 August 2025
thumbnail
Congress Presentation
Case 2 - Polish experience in post-reperfusion STEMI treatment for inpatients and outpatients
31 August 2024
thumbnail
Congress Presentation
Impact of the Coordinated Care Program KOS-Zawal on mortality among patients with myocardial infarction depending on the implanted antiarrhythmic device
11 May 2024
thumbnail
Congress Presentation
Treatment with PCSK9 inhibitors reduces the expression of scavenger receptors CD16, CD36 and CD45 in patients with stable coronary artery disease and elevated Lp(a) levels
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources